Liping Zeng

Title: Innovations of Liping Zeng in Anti-Helicobacter Pylori Drug Development.

Introduction

Liping Zeng is a notable inventor based in Jiangsu, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. Her work focuses on the preparation of zinc linolenate, which has potential uses in treating infections caused by Helicobacter pylori.

Latest Patents

Liping Zeng holds a patent for the "Preparation of zinc linolenate, and application of zinc linolenate in preparing anti-helicobacter pylori drug." This patent outlines a method for synthesizing zinc linolenate, which involves dissolving zinc chloride in sterile water, activating it in a reactor kettle, and then cooling it to room temperature. The process includes the use of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, N-hydroxysulfosuccinimide sodium salt, and linolenic acid, which are activated in nitrogen gas. The resulting zinc linolenate demonstrates a high yield and effective inhibitory properties against Helicobacter pylori.

Career Highlights

Liping Zeng is affiliated with Nanjing Medical University, where she conducts her research and development activities. Her innovative approach to drug formulation has garnered attention in the scientific community, contributing to advancements in pharmaceutical sciences.

Collaborations

Liping Zeng has collaborated with notable colleagues, including Hongkai Bi and Yanqiang Huang. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality and impact of her research.

Conclusion

Liping Zeng's work in the preparation of zinc linolenate represents a significant advancement in the fight against Helicobacter pylori infections. Her innovative methods and collaborative efforts continue to contribute to the field of pharmaceuticals, showcasing the importance of research and development in medical science.